Filing Details

Accession Number:
0000721371-16-000359
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 08:25:15
Reporting Period:
2016-11-10
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 08:25:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
721371 Cardinal Health Inc CAH Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 310958666
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425512 S George Barrett 7000 Cardinal Place
Dublin OH 43017
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2016-11-10 217,995 $30.94 682,226 No 4 M Direct
Common Shares Disposition 2016-11-10 16,954 $70.40 665,272 No 4 S Direct
Common Shares Disposition 2016-11-10 194,441 $71.35 470,831 No 4 S Direct
Common Shares Disposition 2016-11-10 6,600 $71.82 464,231 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Common Shares Disposition 2016-11-10 217,995 $0.00 217,995 $30.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
217,994 2017-08-16 No 4 M Direct
Footnotes
  1. The exercise and sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.76 to $70.75, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 through 4 to this Form 4.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.76 to $71.75, inclusive.
  4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.76 to $71.93, inclusive.
  5. The option, representing a right to purchase a total of 685,989 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011.